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Abstract 
Objectives: For women who have been diagnosed with unilateral breast cancer there is an 
increasing trend for them to request removal of the contralateral healthy breast, so called 
contralateral risk reducing mastectomy (CRRM).   Although indicated in a minority of 
patients for whom the risk of contralateral breast cancer is high (family history, genetic 
mutation carriage), this group of women represents fewer than one-third of women currently 
undergoing CRRM. The current literature is only just beginning to identify patient-reported 
reasons for undergoing CRRM and associated patient reported outcomes. It is unclear 
whether women at high/moderate risk of developing a subsequent primary contralateral 
breast cancer report similar outcomes to those  considered to be at low/average risk.  This 
lack of knowledge provides the rationale for this review.   
 
Methods: A rapid review methodology was undertaken to identify and explore the published 
research literature focused on the longer term (>5 years) psychosocial impacts on women 
(specifically those at low/average risk of developing a future contralateral breast cancer) who 
undergo CRRM.  
Results: 15 studies were identified. No UK studies were identified. High satisfaction rates 
were reported across all the studies.  Dissatisfaction was associated with adverse effects such 
as poor cosmesis, body image changes, femininity, sexual relationships, reoperations and 
reconstructive problems. 
Conclusions: Although studies reported high satisfaction and psycho-social wellbeing 
following CRRM, these primarily focused on women at high familial/genetic risk of 
developing a future contralateral breast cancer and it is therefore unclear whether these 
findings can be extrapolated to women at low/average risk. 
Keywords: Cancer, oncology, rapid review, contralateral, risk reducing, mastectomy, 
satisfaction, outcomes   
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The psycho-social impact of contralateral risk reducing mastectomy (CRRM) on non 
high risk women: a rapid review  
Background 
Breast cancer is the most common cancer in women in the UK, with over 53,000 new cases 
being diagnosed in the UK each year1.Although there is overwhelming evidence of the 
efficacy of breast conservation surgery in achieving excellent local disease control, there has 
been a controversial recent trend towards bilateral mastectomy, not for oncological benefit, 
but for future risk reduction.  Over the past decade the total number of women in England 
who had a bilateral mastectomy doubled2.  For women without cancer, but at high risk of 
subsequent primary cancer development (such as BRCA gene carriers), there is a well-
established benefit both in terms of reducing the risk of cancer by 90+% AND improving 
survival3.  However for women who have been diagnosed with a unilateral breast cancer 
there is a trend for them to request removal of the contralateral healthy breast, so called 
contralateral risk reducing mastectomy (CRRM).  Although indicated in a minority of 
patients for whom the risk of contralateral breast cancer (CBC) is high (family history, 
genetic mutation carriage)4-6, there are no significant survival benefits of undergoing CRRM 
among average risk women (0.1%-0.6 % per year)2,4,7-9.  
Within Europe, neither EUSOMA (the European Society of Breast Cancer Specialists) nor 
EUROPA DONNA (the European Breast Cancer Coalition) have published guidelines on 
CRRM. The 14th St. Gallen International Breast Cancer Consensus Conference in 201510 also 
made little mention of this. The European Society for Medical Oncology (ESMO) breast 
cancer guidelines11 acknowledge that this is an increasingly prevalent option and advise that 
women considering CRRM must be carefully counselled. Within the UK specifically, the 
National Institution for Health and Care Excellence (NICE) has yet to publish any 
recommendations about CRRM, however guidelines are due for review during 2017.  In the 
USA, a consensus statement about RRM and guidelines for how it should be managed have 
recently been published by the American Association of Breast Surgeons which state that for 
the majority of average risk women with unilateral breast cancer CRRM should be 
discouraged as it has no oncological benefit.  
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Although there are a plethora of studies that have focused on womens¶H[SHULHQFHVDQG
outcomes of bilateral risk reducing mastectomy12,13, to date, research  focused on CRRM has 
tended to focus on the oncologic outcomes (risk of CBC, risk reduction with CRRM, lack of 
survival benefit) and on factors impacting on patients¶ decisions to pursue CRRM4,14. The 
current literature is only just beginning to identify patient-reported reasons for CRRM 4. 
Several recent studies that have reported satisfaction following CRRM4,20,  however these 
have been based on groups of women at high risk of developing a contralateral breast cancer. 
It is unclear whether low to average risk women report similar patient reported outcomes. 
This lack of knowledge provides the rationale for this review.   
Aim 
The aim of this rapid review was to identify and explore the published research literature 
focused on patient reported psychosocial impacts of CRRM on women (specifically low to 
average risk women). Specifically the review aimed to answer the following research 
question:  
What psycho-social impact does a CRRM have on women (specifically low to average risk 
women)? 
 
Methods 
Rapid review methodology 
A rapid review methodology was undertaken to enable identification and synthesis of 
published research evidence in a timely and resource-efficient manner15-17.This rapid review 
differs from a full systematic review in three ways. Firstly, searches were restricted to 
bibliographic databases: grey literature was not searched.   Secondly, during the study 
selection stage, not all papers were double-screened. Thirdly, in relation to data extraction 
and synthesis, only key variables of relevance to the review question were extracted.  No 
meta-analysis was planned. 
Searches 
Electronic searches were conducted in the Cochrane Library (Wiley), Medline (EBSCOHost), 
CINAHL (EBSCOHost), PsycINFO (ProQuest), Scopus (Elsevier), and Web of Science 
(Thomson Reuters), on 19 February 2016. The search strategy included search terms in the 
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title/abstract and relevant database subject headings relating to CRRM, combined with search 
terms and subject headings relating to psychosocial outcomes of interest (including quality of 
life, satisfaction, body image, sexuality, self-esteem, and relationships). See Table 1 for an 
indicative search strategy in Medline. No language or date restrictions were applied to the 
searches, although non-English language results were excluded at the screening stage. 
Reference-checking and citation searching were performed in respect of relevant papers, to 
identify additional relevant papers not returned by the searches. Duplicates were removed 
prior to study selection, and the references were managed in a RefWorks database18.  
 
Study selection 
Original empirical studies of women (>18 years) with breast cancer who had undergone 
CRRM, and which reported on psycho-social  outcomes of interest  (including quality of life, 
satisfaction, body image, sexuality, self-esteem and relationships) were included. Studies of 
males, women without breast cancer, women undergoing unilateral mastectomy or bilateral 
risk reducing mastectomy only (or where data relating to CRRM patients could not be 
distinguished), or studies focusing only on physical outcomes were excluded. Books, 
editorials and letters were excluded.  
 
A screening tool incorporating the above inclusion/exclusion criteria was developed and 
piloted on the same 20 papers, by three reviewers (AC, KC, MG). Following this, the lead 
reviewer (AC) undertook the remainder of the title and abstract screening and all the full text 
screening. Two other reviewers (KC, MG) each spot-checked 10 random papers for full-text 
inclusion/exclusion and confirmed agreement. Where there was any doubt regarding study 
inclusion, a consensus was taken. 
 
 
Data extraction and synthesis 
A data extraction sheet was developed and piloted using the same four included studies, by 
two reviewers (AC, MG), to ensure consistency. Data from each of the remaining studies was 
extracted by one of these reviewers and checked by the other. Extracted fields included 
country, study design, study methodology, sample size, outcomes of interest, measurement 
instruments (if applicable), and key findings related to the outcomes of interest. The findings 
were synthesised thematically, in tabular and narrative format, classified according to the 
outcomes of interest.  
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Results 
See Figure 1 for a flow chart summarising the search and screening processes. The database 
searches identified 361 records, resulting in 206 records after the removal of duplicates and 
non-English publications. Following title/abstract screening, 70 full papers were examined, 
from which 15 were included in this review. Reference and citation searches (including 
checking the reference lists of any literature reviews returned in the original searches) yielded 
no further relevant records. Thus in total 15 records19-33, relating to 13 studies, are included in 
this review. 
 
The main characteristics of the included studies are shown in Table 2. 
 
Three of the papers20,22,23 relate to the same population followed up at two different time 
points (first time point was at median FU of  10.7 years, range 1.9-34.4 years) and second FU 
was at a median of 20.2 years (range 11.4-44.5 years) post CRRM. Two papers 20,23 report on 
both surveys but one of these23 reports only in respect of those women who responded to both 
surveys, and has a focus on reconstruction and reoperation on long term satisfaction. The 
third22 paper reports on the first survey only. As these three papers report on different data 
they have been treated as separate (but related) entities in the presentation of the results. 
 
The studies identified were undertaken  in the United States19,20,22-25,28-32, Canada21, Hong 
Kong27, and Sweden 26,33. No UK studies were identified. Findings have been grouped into 
the following headings: satisfaction with the decision to undergo CRRM, overall satisfaction 
with CRRM, impact on psychological health and perceived impact on partners. The key 
findings from the papers in relation to each of these outcomes are presented below. 
 
Satisfaction with the CRRM procedure  
Five papers20,22-24,27were identified. None of the papers focused on low or average risk 
women so it is not possible to sub group analyse according to risk level.  Satisfaction was 
typically measured using Likert scales, with one study22 supplementing this with open-ended 
questions. 
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Within these studies, womens¶ satisfaction with the procedure (either 'satisfied' or 'very 
satisfied') ranged from 67% from a survey27 of 12 women (follow-up at mean 20 months after 
CRRM) to 90% from a survey23 of 269 women (mean 20.2 years post CRRM).  
In the cohort study22 of 583 women who had undergone CRRM (mean 10.3 years post 
CRRM) 83% (n=471) of women reported that they were satisfied with their CRRM, similarly 
83% (n=471) stated that they would choose to have a CRRM DJDLQ+DYLQJµSHDFHRIPLQG¶
knowing the risk of breast cancer in the unaffected breast (contralateral breast) was reduced 
and satisfaction with cosmesis were the main reasons explaining satisfaction.  Only 9% 
(n=52) of women stated they were dissatisfied with their CRRM. Dissatisfaction with 
cosmetic results, adverse symptoms, complications or diminished body image were reasons 
given for this22. Strong associations were made between dissatisfaction with CRRM and 
decreased satisfaction with body appearance, and increased levels of stress in life after 
CRRM22.  
A second survey23 was undertaken with the same cohort of women 10 years later (mean 20.2 
years post CRRM). Of the 269 women (mean 20.2 years post CRRM), 90% (n=243) stated 
they were satisfied with their CRRM. Perception of making an informed choice and current 
quality of life was moderately associated with higher satisfaction with CRRM (r=0.37 and 
0.37, respectively)23.  
Dissatisfaction with CRRM was significantly associated with the need for reoperation due to 
complications with the reconstruction20,22. Similarly, in a smaller study27 which sampled just 
12 women, 6 of whom had reconstructive surgery, only one woman who experienced flap 
failure stated her overall satisfaction with the CRRM was unsatisfactory27. 
 
Satisfaction with decision  
Five papers20,22,23,26,27, relating to three studies investigated womens¶ satisfaction with their 
decision to undergo CRRM, and whether or not they would choose CRRM again. None of the 
studies focused on low or average risk women. A combination of Likert scales, study specific 
measurement tools, and open ended questions were used within the reported studies. No 
study used a validated tool such as the decision regret scale34. 
Most women reported that they were satisfied with their decision and would choose CRRM 
again, with responses ranging from 75% from a survey27 of 12 women (follow-up at mean 20 
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months after CRRM) to 100% in a survey26 of 21 women (follow-up at  median 42 months). 
In two large surveys22,23 of  269 women, 90% and 92% of women at a median of 10.3 and 
20.2 years post CRRM respectively reported that, knowing what they do now, they probably 
or definitely would choose CRRM again.  
Impact of CRRM on body image 
Nine papers 19-24,27-29 relating to seven studies explored the impact of CRRM (with and 
without reconstruction) on womens¶ body image using a range of validated and non-validated 
tools in the short, medium or long term. None of the studies focused on low or average risk 
women. Among the quantitative studies, perceptions of body image were typically measured 
using ordinal scales or Likert scales. One study23  used a validated Body Image Scale. 
Womens¶ overall perceptions of their body image and general satisfaction with their 
appearance were measured by two studies20,22,23,27. More specifically, studies explored 
women's feelings of femininity20,22, sexuality and sexual attractiveness23,28,29, self-
consciousness about their appearance23,24, and satisfaction with the cosmetic result of 
CRRM/reconstruction29.  
Body image and cosmesis post-CRRM emerged as an important theme within these 
studies19,21.  Women expressed positive views of enhanced breast size or pertness, pride in 
survivorship, acceptance of the trade-off of survival at the expense of sub-optimal cosmesis 
and regret at the loss of femininity19.   
Two papers relating to the same large study reported long term follow-up of women with a 
personal and family history of breast cancer (FU median 10.3 years22 (n=583) and median 
20.2 years23(269 women) post CRRM).  At first and second follow-up, body image was 
negatively affected in 33% (n=192) and 31%(n=89) of women respectively. At a median FU 
of 10.3 years post CRRM22, 33% (n=192) of women reported decreased satisfaction with 
their body appearance, and 26%  (n=70) reported adverse effects of CRRM on their sense of 
femininity. At a median FU of 20.3 years post CRRM23, 11%  (n=29) of women reported that 
they felt  less physically attractive, and 15% (n=41) reported feeling less sexually attractive 
since undergoing their CRRM. Feelings of femininity were found to correlate with sexual 
relationships in this study22. In another study, immediate CRRM was found to have a 
significant negative impact on sexuality compared to delayed or no CRRM28. A diminished 
sense of sexuality was reported as a reason for decision regret 29. Self-consciousness about 
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their appearance was reported by between 10- 21% of women in another study24. In a further 
study 27 90% (n=11) of women reported their initial impression of their appearance after 
surgery as being acceptable. Successful reconstruction was significantly associated with 
increased satisfaction with physical appearance and with increased feelings of femininity20. 
Body image was an important factor influencing whether or not women would choose 
CRRM/reconstruction again20. Of 583 women that were surveyed 10 years post CRRM, 69% 
(n=403) underwent CRRM/reconstruction, 84%(n=338) stated that they would choose 
CRRM again, and 73% (n=296) would make the same choice regarding reconstruction.  Most 
commonly, women cited positive effects on body image and self-esteem.20 However, 17% 
(n=68) stated that they would not choose reconstruction again, with adverse body image/poor 
cosmetic outcomes as being the main factors underlying this20. 
Women in the no reconstruction group who said they would still opt for no reconstruction 
gave the most frequently cited reason that they felt comfortable with their body without 
reconstruction (42% n=170). 
At 20 years post CRRM, a smaller percentage of women compared to 10 years said they 
would change their decision: 10%, (n=26) of reconstruction patients and 16% , (n=40 ) of no 
reconstruction patients said they would change their decision. Successful reconstruction and 
use of implants also contributed to better adjustment towards surgical outcomes20.   
 
Impact on psychological health 
Ten papers relating to eight studies specifically examined the impact of CRRM on mental 
health19,20,22-25,30-33. None of the papers reported on differences between low, average or high 
risk women. Psychological health was measured in the short-, medium- and long-term.   A 
combination of Likert and unspecified ordinal scales were used.  A number of validated 
instruments were also used to measure symptoms related to mental health conditions 
including: the Hospital Anxiety and Depression scale33, the 15-item Impact of Events 
Scale25,32, the 17-item Multidimensional Impact Cancer Risk assessment32, the Functional 
Assessment of Cancer Therapy(FACT)-Breast Cancer quality of Life Instrument24, the Centre 
for Epidemiologic Studies-Depressions (CES-D) scale24,30, and the Short-form of the Hopkins 
Symptom Checklist (HSCL-25)25. 
10 
 
 
In one survey20 of 583 women (at median FU of 11.9 years post CRRM), CRRM followed by 
reconstruction was significantly associated with positive feelings of self-esteem (32% (n= 
125) with and 12% (n=21) without reconstruction ± P=0.00002).  Whilst in a survey follow 
up of 269 women (median of 20.2 years post CRRM) this was 26% (n=52) and 16 % (n=9) 
respectively. Differences between reconstruction and non-reconstruction patients was not 
statistically significant20. 
 
The same large study examined emotional stability following CRRM.    Emotional stability 
was reported to be adversely affected in 23% (n= 65) of women in the first survey (median  
10.7 years post CRRM) 23.Whilst in the second survey (mean 20.2 years post CRRM) only 
14% (n=19) reported an adverse emotional effect23.  In both the first and the second survey 
there was no statistically significant difference in emotional stability between those who 
underwent reconstruction following CRRM compared to those with no reconstruction20. 
 
One study22 reported perceived stress following CRRM with 17% (n=100) of women 
reporting that they experienced stress in life following CRRM.  Stress was negatively 
correlated with self-esteem (r=0.33) and emotional stability (r=0.21). 
 
Three studies reported on anxiety following CRRM19,31,33. In surveys33 of 60 women at 
different time points, prior to CRRM, 30% (n=18) of patients scored above the cut off point 
for clinically relevant levels of anxiety (>8) on the anxiety subscale and at 6-month and 2-
year post CRRM,  37% (n=22) and 22% (n=13) respectively. In another study19 4% (n=25) of 
women post CRRM commented on feelings of relief from breast cancer worry or anxiety 
since having the surgery (median follow-up 9 years (range 3-22). A further study31  reported 
no significant difference in levels of anxiety in women who chose CRRM compared to those  
having breast-conserving surgery or unilateral mastectomy only. 
 
Four studies focused on depression following CRRM24,30,31,33. In one study, albeit with very 
small numbers precluding statistical analysis, rates of depression varied very little before and 
after CRRM33.  They found 13% (n=8) of patients at baseline,  12% (n=7) at 6 months and 
8% (n=5) at 2 years post CRRM had evidence of depression, using a threshold of  >8 on the 
depression subscale as indicative of clinically relevant depression.  In another study24 of 519 
women who had undergone CRRM between 1979-1999, 27% (n=14) of women studied had 
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met the Centre for Epidemiologic Studies-Depression (CES-D) threshold for depression. In 
another study30 25% (n=114) of women who had undergone CRRM in the past had 
depressive symptoms at the time of the survey (the mean time since CRRM was not reported 
but 60% women had CRRM within the last 10 years). 
 
Two studies25,32 found that CRRM was not associated with, or a predictor of, cancer specific 
distress.  
 
One study24 focused on contentment with life following CRRM and found that of the 580, 
women who had CRRM between 1979-1999, 76.3% (n=396) reported significant 
contentment with their life post CRRM, and only 7.3%(n=38) reported poor levels of 
contentment. There were no differences between those having CRRM and those having 
CRRM/reconstruction24.   This rather historic time period largely predated clinical gene 
testing so few women will have had risk assessment and counselling according to modern 
standards. 
 
Another study33  used the Short Form 36 Health Survey (SF-36, validated Swedish version) 
to report on health status following CRRM and found no statistically significant differences 
between preoperative and postoperative (both at 6-months and 2-years) assessments for any 
of the SF-36 subscales.   At 6 months post CRRM, patients scored lower on emotional 
domains when compared to preoperative values.  This was considered clinically significant, 
although this may have reflected the emotional impact of the end of the cancer treatment 
spell, which is often associated with depression, rather than the CRRM itself, although this 
was not specified33.   However, two years after CRRM, a positive clinical difference (an 
increase in SF-36 score of >5) in social functioning and mental health was found33. It should 
be noted that the SF36 is a generic health status instrument and more sensitive tools are 
available to specifically measure breast cancer and breast surgery related outcomes. 
 
Impact of CRRM on relationships with partners 
Nine papers19-24,27,31,33 relating to seven studies explored the impact of CRRM on personal 
relationships in the short-, medium- and long-term using a variety of validated and non-
validated tools. One study33 used a specific sexual activity questionnaire (SAQ - Swedish 
version).  
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Three studies20,22-24,27  reported specifically on the extent to which sexual relationships had 
been affected post CRRM.  In two studies22,23 24% (n=143) and  23% (n=138) respectively , 
stated that sexual relationships had been adversely affected 10 and 20 years post CRRM. 
Changes in satisfaction with body appearance were correlated with changes in sexual 
relationships (r=0.46), feelings of femininity correlating with sexual relationships (r=0.33) 
and levels of stress significantly correlated with sexual relationship(s) (r = -0.23)23. In the 
same study, significantly more women who had undergone reconstruction reported adverse 
effects on sexual relationships at the first follow-up, than those who had not (24% and 21% 
respectively; p=0.03), however at the second follow-up time point the difference was not 
statistically significant (23% and 18% respectively)20.   One study found that, of those who 
had undergone CRRM, 41% (n=213) reported satisfaction with their sex life24. In another 
study33exploring sexual activity using a self-assessment questionnaire of 60 women 2 years 
post CRRM, over half of the women reported problems/dissatisfaction with their body 
appearance, scars, femininity and attractiveness across 2 of the body image domains33. One 
study reported on perceived strained personal relationships prior to and following CRRM  
and found no statistically significant differences between pre and post-operative scores 31.   
Three studies19,21,27 reported that women were sensitive to the reaction of their partners 
following CRRM.  Two of these studies19,27  UHSRUWHG WKDW VSRXVHV¶ DWWLWXGHV DQG support 
contributed to the overall adjustment of women. They also reported that among those who 
were married but sexually inactive (50% n=3/6), lack of sexual activity predated the CRRM 
and simply persisted afterwards.  Reasons included decreased libido after cancer treatment, 
menopause and fatigue. They also found that the sexually inactive single participants 
appeared to adjust better to the cosmetic results of the surgery21.  
 
Conclusions and recommendations made within the reviewed studies 
Conclusions from each of the reviewed studies have been grouped into 5 broad categories: 
1. Additional decision support and education aids are needed not only relating to 
whether to have CRRM but also to what type of reconstructive surgery (if any) 
to select (6/15 studies) 
2. Women should be informed of the potential risks and adverse outcomes 
(specific consideration given for sexuality, psycho-social outcomes and body 
image changes) (9/15 studies) 
13 
 
3. The role of the health professional (surgeon, specialist nurse, psychologist) 
was emphasised in supporting informed decision making and guidance may be 
helpful to optimise informed decision making.  (4/15 studies) 
4. Psycho-social and counselling support should be provided  both before and 
after such surgery (5/15 studies) 
Discussion 
This review has synthesised the current evidence from 15 studies focused on the psychosocial 
impact of CRRM. All studies reported high levels of satisfaction following CRRM. Two 
studies reporting on the same cohort of women (mean 10.3 and 20.2 years post CRRM) found 
satisfaction to be consistently stable over a 10 year period22,23. Reducing the risk of a CBC in 
the future and therefore reducing cancer related anxiety,  and satisfaction with cosmesis, were 
key themes running across all studies explaining satisfaction among this group.  
Dissatisfaction was associated with adverse effects, with poor cosmesis, body image changes, 
femininity, sexual relationships, reoperations for acute and longer term complications and 
reconstructive problems cited as significant concerns19-24,29. 
Of the 15 papers included in the review, 13 focused exclusively on women who were 
considered to be at high risk (family history, genetic mutation carriers) of developing a 
subsequent contralateral breast cancer. Only 319, 29, 30 of the studies included women that were 
at low to average risk of developing a subsequent breast cancer. None of the studies reported 
any differences between these groups. 
Since undertaking this review, a systematic review focusing on factors and predictors 
influencing choice and satisfaction with CRRM has been published. This review primarily 
focuses on factors influencing decisions to undergo CRRM and rather than longer term 
outcomes.  The review reported that  overall, women appeared satisfied with their decision to 
undergo CRRM, and similar to our findings, adverse/diminished body image, poor cosmetic 
result, complications, diminished sense of sexuality, emotional issues and perceived lack of 
education regarding alternative surveillance/CRRM efficacy were cited as reasons for 
dissatisfaction4.  
Although satisfaction rates were high, the reasons for dissatisfaction seem to suggest that 
there is a need for additional information resources to support informed decision making 
regarding the decision to have CRRM and/or immediate/delayed reconstruction (or not) and 
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the provision of evidence based information on  the risks and benefits of CRRM may be 
warranted. Women need to be more fully informed of the impact of CRRM on long term 
survival, recurrence risk, post-operative complications and possible quality of life and 
psychological outcomes6,12,14. This seems imperative among low/average risk women where 
there are no significant survival benefits of undergoing CRRM. 
 
Although not part of this review, the role and influence of health professionals and partners 
on treatment decisions became apparent and further investigation is warranted.  
 
Limitations of this study 
In common with all rapid reviews, this review has limitations compared with a full systematic 
review. By limiting the search to English language publications and not contacting authors 
for additional relevant research, relevant unpublished reports, grey literature, and papers 
published in other languages, some data may have been missed. By performing a light-touch 
quality assessment there was a risk of over-reliance on and misinterpretation of poor research. 
The disadvantage of single-screening some of the papers by the lead author was mitigated 
against by piloting the screening tool by three authors, and two authors further checking a 
sample of screened papers. All data extractions were also double-checked by a different 
reviewer.  
 
Conclusion 
Although satisfaction with CRRM was consistently reported across all studies, the focus of 
these studies was largely high familial/genetic risk women rather than low/average risk 
women and it is therefore unclear from this review whether such findings can be extrapolated 
to low/average risk women. Given the growing numbers of CRRM being performed in 
women considered to be at low/average risk of developing a new primary CBC for whom 
there will be  no significant survival benefit of undergoing a CRRM,  there is a need for 
improved decision support in order to ensure women are fully aware of the risks and benefits 
of CRRM (specifically long terms survival, recurrence risk, post-operative complications and 
short/medium and longer term quality of life/psychological outcomes) in order to make 
informed decisions regarding this complex decision.  However the evidence from this review 
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is that the psychological outcomes are largely positive, even in the long term, and this should 
be considered when supporting women in informed decision making. 
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Table 1. Indicative search strategy in Medline 
TI = title words; AB = abstract words; MH = database subject heading 
S1 
TI "contralateral risk reducing mastectom*" OR AB "contralateral risk reducing 
mastectom*" OR TI "contralateral surger*" OR AB "contralateral surger*" 230 
S2 
TI "contralateral risk reduc* mastectom*" OR AB "contralateral risk redu* 
mastectom*" 17 
S3 S1 OR S2 247 
S4 (MH "Quality of Life") 131,267 
S5 TI "quality of life" OR AB "quality of life" 178,080 
S6 
TI "patient reported outcome measures" OR AB "patient reported outcome 
measures" 1,013 
S7 
TI "patient reported experience measures" OR AB "patient reported experience 
measures" 14 
S8 TI psychological OR AB psychological 148,789 
20 
 
S9 TI psychosocial OR AB psychosocial 67,719 
S10 (MH "Patient Satisfaction+") 67,044 
S11 TI satisfaction OR AB satisfaction 90,107 
S12 TI wellbeing OR AB wellbeing 7,516 
S13 (MH "Body Image") 13,976 
S14 TI "body image" OR AB "body image" 7,428 
S15 (MH "Emotions+") 184,009 
S16 TI regret* OR AB regret* 2,917 
S17 TI relationship* OR AB relationship* 971,697 
S18 TI partner* OR AB partner* 119,789 
S19 TI "sexual function*" OR AB "sexual function*" OR TI sexuality OR AB sexuality 20,342 
S20 (MH "Mental Disorders+") 1,012,537 
S21 TI mental* OR AB mental* 255,405 
S22 TI depress* OR AB depress* 349,415 
S23 TI anxiet* OR AB anxiet* 130,565 
S24 TI stress OR AB stress 512,998 
S25 TI self-esteem OR AB self-esteem 15,311 
S26 TI ( behaviour* OR behavior* ) OR AB ( behaviour* OR behavior* ) 886,130 
S27 TI emotion* OR AB emotion* 133,613 
S28 
S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 
OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR 
S26 OR S27 OR S28 OR S29 OR S30 3,728,026 
S29 S3 AND S28 66 
 
 
 
 
 
 
 
Figure 1. Document flow diagram 
 
 
Records identified through 
database searches  
(n = 361) 
Records excluded as 
duplicates and non-English 
language  
21 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.Main characteristics and outcomes of the papers reviewed 
Study, country, 
design 
Study aim(s) 
(relevant to this review) 
Sample size, study population, 
time of follow-up (if given) 
(relevant to this review) 
Outcome 
categories 
of findings 
relevant to 
this review 
Altschuler et al. 
(2008)19 
To assess and compare the 
multidimensional and psychosocial 
For the qualitative element:  
n=327 women (of whom n=249 
Satisfaction 
with decision 
22 
 
 
United States 
 
Qualitative/Quantitative 
(Qualitative element 
relevant to this review)   
 
Survey 
 
effect of risk reducing mastectomy 
(bilerateral and contralateral) in 
women with and without a 
personal history of breast cancer 
had CRRM and n=78 had 
bilateral prophlyactic 
mastectomy) 
 
Women who had had risk 
reducing mastectomy between 
1979 and 1999, aged 18-80 
years 
 
Follow-up post CRRM: 3-22 
years (median 9 years) 
Body image 
Relationships 
Mental health 
Boughey*et al. 
(2015)20 
 
United States 
 
Quantitative 
 
Two surveys 
 
To evaluate the long-term 
satisfaction with CRRM and 
compare satisfaction between 
those with/without breast 
reconstruction; to examine the 
adverse aspects that patients 
attribute to reconstruction and the 
subsequent effect on psychosocial 
consequences. 
First survey: n=583 women (of 
whom n=403 underwent 
reconstruction)  
 
Second survey: n=269 women 
(of whom n=210 underwent 
reconstruction) 
 
Women with unilateral breast 
cancer and a family history of 
breast cancer who underwent 
CRRM. Age at first survey 28-92 
years 
 
Follow-up post CRRM, first 
survey: 1.9-35.4 years (mean 
11.9 years)** 
Follow-up post CRRM, second 
survey: 11.4-44.5 years (mean 
20.2 years) 
Satisfaction 
with 
procedure 
Satisfaction 
with decision 
Body image 
Relationships 
Mental health 
Frost*et al. (2005)22 
 
United States 
 
Quantitative 
 
Survey 
To investigate: satisfaction with 
CRRM and factors associated with 
satisfaction/dissatisfaction; factors 
associated with 
satisfaction/dissatisfaction after 
CRRM;  how reconstruction 
affects satisfaction after CRRM; 
how does CRRM affect women's 
long-term psychological and social 
function, and stress levels  
n=583 women 
 
Women with unilateral breast 
cancer and a family history of 
breast cancer who underwent 
CRRM. Age at first survey 28-92 
years 
 
Follow-up post CRRM: mean 
10.3 years** 
Satisfaction 
with 
procedure 
Satisfaction 
with decision 
Body image 
Relationships 
Mental health 
Frost*et al. (2011)23 
 
United States 
 
Quantitative 
 
Survey 
 
To evaluate the long-term 
consistency of satisfaction with 
CRRM and adverse psychological 
and social effects; to explore the 
effect of informed decision-
making, personality traits, and 
quality of life (QOL) on 
satisfaction. 
n=269 women (who responded 
to first and second surveys) 
 
Women who with unilateral 
breast cancer and a family 
history of breast cancer who 
underwent CRRM. Age at CRRM 
24.1-75.3 years; age at first 
survey 31.7-84.3 years; age at 
second survey 41.8-94.0 years. 
 
Follow-up post CRRM, first 
survey: 1.9-35.4 years (mean 
10.7 years) 
Follow-up post CRRM, second 
survey: 11.4-44.5 years (mean 
20.2 years) 
Satisfaction 
with 
procedure 
Satisfaction 
with decision 
Body image 
Relationships 
Mental health 
Covelli et al. (2015)21 
 
Canada 
 
Qualitative 
Semi-structured 
interview 
To explore patients' perspectives 
on decision making for early stage 
breast cancer and women's choice 
for mastectomy 
n=14 women (who had unilateral 
mastectomy  + CRRM) 
 
Women who had undergone either 
UM or UM + CRRM within the 
previous 9-12 months. Of the 
UM+CRRM patients, age range 37-
69 years, median 46 years. 
Body image 
Relationships 
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Follow-up post CRRM: 9-12 months 
 
Geiger et al. (2006)24 
 
United States 
 
Quantitative 
 
Survey 
To understand the psychosocial 
outcomes after CRRM; to 
determine long-term contentment 
with quality of life and to examine 
factors associated with less 
contentment with quality of life 
n=519 women (who had CRRM) 
 
Women who had been 
diagnosed with breast cancer 
from 1979-1999, aged 18-80 at 
diagnosis. 
 
Follow-up post CRRM: not 
reported 
Satisfaction 
with 
procedure 
Body image 
Relationships 
Mental health 
Graves et al. (2007)25 
United States 
 
Quantitative 
 
Interview 
 
To determine the predictors and 
impact of CRRM on psychological 
outcomes 
n=89 women (who had CRRM by 
the 12-month follow-up, from 
n=435 women affected with 
unilateral breast cancer who 
received positive uninformative 
BRCA1/2 genetic test results) 
 
Participants (N = 435) were 
women affected with unilateral 
breast cancer who received 
BRCA1/2 test results through the 
Lombardi Comprehensive 
&DQFHU&HQWHU¶V&DQFHU
Assessment and Risk Evaluation 
(CARE) program from 1995 to 
2000. 
 
Follow-up post CRRM: <12 
months 
 
Mental health 
Isern et al. (2008)26 
 
Sweden 
 
Quantitative 
 
Survey 
To investigate the long-term 
aesthetic outcome, patient 
satisfaction, health related quality 
of life and complication rates 
among women undergoing CRRM 
and immediate reconstruction  
n=21 women (who underwent 
CRRM) 
 
Women who underwent CRRM 
with immediate breast 
reconstruction, all with a 
previous ipsilateral cancer.  16 of 
these women had a previous 
cancer treated with mastectomy.  
5 had a previous breast cancer 
and nonradical breast conserving 
surgery. 
 
Follow-up post CRRM: 7-99 
months (median 42 months) 
Satisfaction 
with decision 
Kwong & Chu (2012)27 
 
Hong Kong 
 
Qualitative/Quantitative 
 
Semi-structured 
interview 
To explore the impact of CRRM 
from the subjective account of 
high-risk unilateral breast cancer 
survivors following a genetic 
BRCA1 or BRCA2 diagnosis 
n=12 women (comprising n=11 
confirmed BRCA 1/2 mutated 
gene carriers and n=6 had 
reconstructive surgery with 
CRRM) 
 
Women who had CRRM after 
BRCA1/2 genetic testing. Age 
34-55 years.  
 
Follow-up post CRRM: 11-34 
months (mean 21 months) 
Satisfaction 
with 
procedure 
Satisfaction 
with decision 
Body image 
Relationships 
 
Lee et al. (2013)28 
 
United States 
 
Quantitative 
 
Survey 
To examine short-term QOL 
impairment in premenopausal 
patients with breast cancer 
(diagnosed before the age of 50 
years), including self-perception, 
views of their sexuality, impact of 
surgical and oncologic treatment, 
n=143 women of whom n=67 
women had undergone CRRM 
(n=54 underwent immediate 
CRRM, n=13 underwent delayed 
CRRM) 
 
Women diagnosed between the 
Body image 
24 
 
femininity, and changes in 
relationships with partners and 
other family members. 
ages of 18 and 49 y with non 
metastatic breast cancer and  6 
months from last curative 
treatment (surgery, 
chemotherapy, radiation) except 
for ongoing hormone therapy 
 
Follow-up post CRRM
months (mean not reported) 
Montgomery et al. 
(1999)29 
 
United States 
 
Qualitative 
 
Semi-structured 
interview 
To understand which factors may 
cause a women to regret her 
decision to undertake CRRM 
n=18 women who expressed 
regret from an overall survey 
response of n=296 women 
 
Women who had undergone 
CRRM and who reported they 
regretted their decision to have 
CRRM (ie would not have a 
CRRM againnor would 
recommend it to another woman 
at similar risk). Mean age for the 
whole sample (ie those who did 
or did not regret) at CRRM was 
53.8 years (range 27-80, median 
53). 
 
Follow-up post CRRM: 0.25-43.8 
years (mean 10.9 years) 
Satisfaction 
with decision 
Body image 
Nekhlyudov et al. 
(2005)30 
 
United States 
 
Quantitative 
 
Survey 
To determine women's reported 
decision making roles regarding 
CRRM, including trends over time, 
and to explore the association of 
decision making roles with 
psychological outcomes, including 
satisfaction, long-term concern 
about breast cancer, and 
depressive symptoms 
n=431 women 
 
Women aged 18-80 years with 
CRRM between 1979 and 1999. 
 
Follow-up post CRRM: mean 
10.0 years 
Satisfaction 
with decision 
Mental health 
Portschy et al. (2015)31 
 
United States 
 
Quantitative 
 
Survey 
To evaluate contralateral breast 
cancer risk perception changes 
over time among breast cancer 
patients 
n=43 women of whom n=11 
women had undergone CRRM 
 
Women over the age of 18 with 
Ductal carcinoma in situ or 
invasive breast cancer (newly 
diagnosed unilateral breast 
cancer).  Mean age of thosewho 
had CRRM was 47 years 
 
Follow-up post CRRM: 1.8-3.5 
years (mean 2.6 years)  
(reporting on n=43 women) 
Satisfaction 
with decision 
Relationships 
Mental health 
 
Tercyak et al. (2007)32 
 
United States 
 
Quantitative 
 
Interview 
To investigate the impact of 
CRRM during the immediate 
postdiagnostic period (1 month 
after BRCA1/2 testing) and after 
the completion of adjuvant 
treatment (12 months after testing) 
n=29 and n=44 women who had 
undergone CRRM at 1- and 12-
months respectively, from n=147 
and n=149 women completing 
the 1- and 12-month follow-up 
 
Women newly diagnosed with 
ductal carcinoma in situ (DCIS) 
to stage IIIa breast cancer, who 
had not received definitive local 
breast cancer treatment, and had 
received genetic counselling and 
testing. Mean age 45 years 
(range 23-70 years). 
 
Follow-up post BRCA 1/2 testing: 
1 and 12 months 
Mental health 
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Unukovych et al. 
(2012)33 
 
Sweden 
 
Quantitative 
 
Questionnaire 
To prospectively (before CRRM, 6 
months and 2 years after CRRM) 
evaluate HRQoL, anxiety and 
depression, sexuality and body 
image in breast cancer patients 
with a family history, undergoing 
CRRM with immediate breast 
reconstruction 
n=60 women responded to any 
of the three questionnaires, with 
n=45 women responding to the 
pre-CPN survey, n=49 at the 6-
month survey, and n=45 at the 
24-month survey 
 
Women with a confirmed family 
history of breast cancer who 
underwent CRRM with 
immediate breast construction, 
and who had a consultation with 
a medical psychologist before 
CRRM. Age at CRRM 25-65 
years. Excluded women who 
underwent CRRM in conjunction 
with breast cancer surgery.  
Majority (57/60) patients had 
already undergone breast cancer 
surgery and adjuvant treatment 
prior to CRRM. 
Body image 
Relationships 
Mental health 
*The papers   Boughey et al. (2015),  Frost et al. (2005) and Frost et al. (2015) relate to the same large cohort 
study.  
**The papers Boughey et al. (2015) and Frost et al. (2005), although referring to the same population for the first 
survey, report different mean times of follow-up since CRRM. 
